Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Curebound
Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research
February 11, 2026
From
Curebound
Via
Business Wire
Curebound Appoints MedTech Innovator Rick Valencia as Chair of Its Board of Directors
January 20, 2026
From
Curebound
Via
Business Wire
Curebound Awards $8.5 Million for 23 Cancer Research Studies, Including $1 Million Cure Prize
December 10, 2025
From
Curebound
Via
Business Wire
Curebound Partners with FOX 5/KUSI for Week of Giving Textathon Dec. 1-7
December 02, 2025
From
Curebound
Via
Business Wire
Curebound Names Robin Toft as Chief Executive Officer
December 02, 2025
From
Curebound
Via
Business Wire
Curebound Cancer Challenge Raises $4 Million to Fund Vital Research in San Diego
September 25, 2025
From
Curebound
Via
Business Wire
Curebound Challenges San Diego to Help Raise Vital Funding Amid Billions in Federal Grant Cuts that Threaten Cancer Research
June 12, 2025
From
Curebound
Via
Business Wire
Curebound Concert for Cures with Elton John Raises $11.5 Million at Largest and Highest Grossing Fundraiser for Cancer Research in San Diego’s History
May 19, 2025
From
Curebound
Via
Business Wire
Curebound Closes 2024 by Awarding 17 New Cancer Research Grants, Bringing Total Annual Funding to $8.25M
January 14, 2025
From
Curebound
Via
Business Wire
Curebound Envisions World Without Cancer, Invites Community to Donate by December 31 to Accelerate Research Momentum
December 16, 2024
From
Curebound
Via
Business Wire
Padres Pedal the Cause Is Now Curebound Cancer Challenge, Kicks Off with $1.1 Million Philanthropic Gift as Organization Doubles Down on Mission to End Cancer
November 21, 2024
From
Curebound
Via
Business Wire
Curebound Whitworth Legacy Circle Invites Philanthropists to Join its Movement to Fund Next-Generation Cancer Research
October 24, 2024
From
Curebound
Via
Business Wire
Curebound Announces Eight Grants Totaling $2 Million in Funding to Address Emerging Areas of Opportunities in Cancer Research
September 24, 2024
From
Curebound
Via
Business Wire
Immuno-Oncology Researchers Have Leveraged $200,000 in Seed Grant Funding from Curebound to Secure $9.6M in NIH Follow-On Funding and Launch Clinical Trial for Head and Neck Cancer Immunotherapy
September 12, 2024
From
Curebound
Via
Business Wire
Research Funded by Curebound Gains Continued Momentum with Follow-On Funding for Cancer Research Clinical Trials and Scientific Accolades for New AI Precision-Oncology Platform
August 21, 2024
From
Curebound
Via
Business Wire
Curebound’s 2024 Padres Pedal the Cause Raises Over $3M to Accelerate New Cancer Research Discoveries to Clinical Application
June 24, 2024
From
Curebound
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today